Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Public ClinicalTrials.gov record NCT04604509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PISCES I: Precision Implemented Smoking Cessation Evaluation Study
Study identification
- NCT ID
- NCT04604509
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 2,010 participants
Conditions and interventions
Conditions
Interventions
- Bupropion Hydrochloride Controlled-release Drug
- Nicotine Replacement Drug
- Questionnaire Administration Other
- Tobacco Cessation Counseling Other
- Varenicline Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2020
- Primary completion
- Dec 30, 2028
- Completion
- Dec 30, 2028
- Last update posted
- May 3, 2026
2020 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cigarette Smoking-Related Carcinoma trials
Other public records listing Cigarette Smoking-Related Carcinoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT06213532: CONNECTing to LungCare Recruiting
- NCT06697496: A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial Not yet recruiting
- NCT07493252: A Behavioral Application for Improving Smoking Cessation Among Smokers Not yet recruiting
- NCT07604246: Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES Trial Not yet recruiting
- NCT06038526: Evaluation of Canakinumab in High-Risk Former-Smokers Active, not recruiting
- NCT05121051: Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04604509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04604509 live on ClinicalTrials.gov.